These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25016757)

  • 21. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
    Mehta D; Lim HW
    Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
    Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
    Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the mechanism of narrow-band UVB therapy for psoriasis.
    Keaney TC; Kirsner RS
    J Invest Dermatol; 2010 Nov; 130(11):2534. PubMed ID: 20944634
    [No Abstract]   [Full Text] [Related]  

  • 25. Narrowband ultraviolet B in the treatment of psoriasis: the journey so far!
    Dogra S; De D
    Indian J Dermatol Venereol Leprol; 2010; 76(6):652-61. PubMed ID: 21079308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
    Rácz E; Prens EP; Kurek D; Kant M; de Ridder D; Mourits S; Baerveldt EM; Ozgur Z; van IJcken WF; Laman JD; Staal FJ; van der Fits L
    J Invest Dermatol; 2011 Jul; 131(7):1547-58. PubMed ID: 21412260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narrowband ultraviolet B versus psoralen plus ultraviolet A therapy for severe plaque psoriasis: an Indian perspective.
    Chauhan PS; Kaur I; Dogra S; De D; Kanwar AJ
    Clin Exp Dermatol; 2011 Mar; 36(2):169-73. PubMed ID: 20545955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis.
    Kirke SM; Lowder S; Lloyd JJ; Diffey BL; Matthews JN; Farr PM
    J Invest Dermatol; 2007 Jul; 127(7):1641-6. PubMed ID: 17380117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA; Youssef N; Bayoumy NM
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective treatment with balneophototherapy and narrowband UVB monotherapy reduces skin homing Th17/Tc17 and Th22/Tc22 effector cells in peripheral blood in patients with psoriasis.
    Eysteinsdóttir JH; Sigurgrímsdóttir H; Einarsdóttir HK; Freysdottir J; Agnarsson BA; Ólafsson JH; Sigurgeirsson B; Lúðvíksson BR
    J Dermatol Sci; 2019 Nov; 96(2):110-112. PubMed ID: 31761387
    [No Abstract]   [Full Text] [Related]  

  • 31. Soluble tumor necrosis factor alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2005 Aug; 21(4):210-1. PubMed ID: 15998370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Narrow Band Ultraviolet B on Serum Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Psoriasis.
    Chen HQ; Li X; Tang R
    Am J Ther; 2016; 23(3):e655-62. PubMed ID: 26308328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating the Science of Psoriasis.
    Gordon KB
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S64. PubMed ID: 27526392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current developments in phototherapy for psoriasis.
    Morita A
    J Dermatol; 2018 Mar; 45(3):287-292. PubMed ID: 29369396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis.
    Rose RF; Batchelor RJ; Turner D; Goulden V
    J Am Acad Dermatol; 2009 Aug; 61(2):259-62. PubMed ID: 19493587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of narrowband ultraviolet B treatment on endocannabinoid plasma levels in patients with psoriasis.
    Magina S; Vieira-Coelho MA; Moura E; Serrão MP; Piscitelli F; Moura D; Di Marzo V
    Br J Dermatol; 2014 Jul; 171(1):198-201. PubMed ID: 24641781
    [No Abstract]   [Full Text] [Related]  

  • 38. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?
    Pugashetti R; Lim HW; Koo J
    J Dermatolog Treat; 2010 Nov; 21(6):326-30. PubMed ID: 19895327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.
    Wolf P; Hofer A; Legat FJ; Bretterklieber A; Weger W; Salmhofer W; Kerl H
    Br J Dermatol; 2009 Jan; 160(1):186-9. PubMed ID: 19067710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis.
    Myśliwiec H; Kiluk P; Myśliwiec P; Żelazowska-Rutkowska B; Baran A; Flisiak I
    Clin Exp Dermatol; 2017 Oct; 42(7):786-790. PubMed ID: 28748592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.